Parathyroid Adenoma
Symptoms, Doctors, Treatments, Advances & More

Parathyroid Adenoma Overview

Save information for later
Sign Up

Learn About Parathyroid Adenoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Parathyroid Adenoma Local Doctors?
Distinguished in Parathyroid Adenoma
Otolaryngology
Distinguished in Parathyroid Adenoma
Otolaryngology

Swedish Head And Neck Surgery

1221 Madison Street, Suite 1523, 
Seattle, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Joseph Sniezek is the Medical Director of Head & Neck Endocrine Surgery for Swedish Health Services. Dr. Sniezek graduated from West Point in 1990 and the Vanderbilt University School of Medicine in 1994. After completing an Otolaryngology residency in 1999, he performed a two-year fellowship at Vanderbilt in head and neck oncologic and reconstructive surgery. He has served as a department chief, residency program director, and subsequently as the Consultant to the Surgeon General of the Army for Otolaryngology/Head & Neck Surgery. His clinical practice focuses on the treatment of head and neck masses and tumors, with a particular interest in thyroid and parathyroid disease. In 2015, he was elected Teacher of the Year by the Swedish General Surgery Residency. He completed a Masters in Business Administration at the University of Washington in 2016. Dr. Sniezek has also been perennially recognized with Seattle Met and Seattle Magazine's Top Doctor award. Dr. Sniezek is rated as a Distinguished provider by MediFind in the treatment of Parathyroid Adenoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Parathyroid Adenoma, Parathyroid Cancer, Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Sniezek is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Sniezek is currently accepting new patients.

Elite in Parathyroid Adenoma
Endocrinology
Elite in Parathyroid Adenoma
Endocrinology

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
Languages Spoken:
English
Offers Telehealth

Naifa Busaidy is an Endocrinologist practicing medicine in Houston, Texas. Dr. Busaidy is rated as an Elite provider by MediFind in the treatment of Parathyroid Adenoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Parathyroidectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Parathyroid Adenoma
Elite in Parathyroid Adenoma
Florence, IT 

Maria Brandi practices practicing medicine in Florence, Italy. Brandi is rated as an Elite expert by MediFind in the treatment of Parathyroid Adenoma. They are also highly rated in 51 other conditions, according to our data. Their clinical expertise encompasses Osteoporosis, Hypophosphatemia, X-Linked Hypophosphatemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).

What are the latest Parathyroid Adenoma Clinical Trials?
A Phase II Study of Accuracy of 18F-Fluorocholine PET/MRI and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Background: People have 4 parathyroid glands near the thyroid gland in the neck. Surgery is needed to remove a parathyroid gland that is too large or has a tumor. These glands can be in different places, so doctors use an imaging scan with contrast dye to help find them before surgery. Researchers want to know if a different type of scan and a new tracer can make it easier to find the tumors in the parathyroi...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase II Basket Study to Evaluate the Tissue-agnostic Efficacy of Anti-Programmed Cell Death Protein 1 (Anti-PD1) Monoclonal Antibody in Patients With Advanced Rare Tumors

Summary: The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with advanced or metastatic rare tumors. The study aims to treat rare malignancies with PD-L1 expression (CPS ≥ 10), regardless of the tumor's tissue type or location. Patients who have not responded to standard treatments will be included, and ...